Bronchiectasis

Among patients with bronchiectasis, disease severity was higher with a blood eosinophil count less than 50 cells/L or higher than 300 cells/L, according to results published in CHEST.

HONOLULU — Patients with non-cystic fibrosis bronchiectasis and persistent Aspergillus fumigatus faced a heightened risk for exacerbations, according to research presented at the CHEST Annual Meeting.

The CHEST Annual Meeting will be held Oct. 8 to 11 in Honolulu with a broad focus on celebrating community and connecting with others through storytelling.

Fulfilling criteria for suspected bronchiectasis raised the risk for all-cause mortality among adults with a smoking history, even if they had normal lung function, according to results published in Annals of Internal Medicine.

Patients with bronchiectasis who produced discolored sputum appeared more likely to experience exacerbations, hospitalization and death, according to a poster presented at the European Respiratory Society International Congress.

The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer-issued press release.